May 12, 2020
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
Nov 21, 2019
FDA approves new treatment for adults with partial-onset seizures
Feb 25, 2019
Benzodiazepine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Nov 30, 2018
UCB presents latest research at 2018 American Epilepsy Society Annual Meeting demonstrating neurology commitment and leadership
Oct 25, 2018
Aquestive Therapeutics Announces Completion of Diazepam Buccal Film Adult Epilepsy Monitoring Unit (EMU) Clinical Study with Positive Topline Results
Jul 09, 2018
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon® Patch
Apr 27, 2018
AcelRx receives positive CHMP opinion for DZUVEO(TM) for management of acute moderate to severe pain in medically monitored settings
Jan 09, 2018
GT Biopharma Announces Completion of Dosing in Phase 1 Clinical Trial of GTP-004 for Myasthenia Gravis
Dec 22, 2017
Information Update - New warnings regarding the use of certain sedative and anesthetic drugs during pregnancy and in early childhood
Dec 01, 2017
FDA Approval of Heparin Sodium Injection Continues to Demonstrate Mylan's Deep Expertise in Developing Complex Products
Oct 26, 2017
Mylan Wins UK Court Ruling Related to Copaxone® 40 mg/mL Patent
Oct 04, 2017
Mylan Confirms U.S. Launch of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and Generic for Copaxone® 20 mg/mL Once-Daily
Sep 13, 2017
Axium Pharmaceuticals Inc. Announces Filing Of Registration Statement On Form S-1
Aug 14, 2017
Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL, Due to Misprinted Dosing Droppers Supplied with the Product